相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease
Prasanna Venkataraman et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
Pierandrea Vinci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Trends, Management, and Outcomes of Acute Myocardial Infarction Hospitalizations With In-Hospital-Onset Versus Out-of-Hospital Onset: The ARIC Study
Melissa C. Caughey et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background
Alessandro Bolli et al.
CIRCULATION (2021)
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data
Gemma A. Figtree et al.
LANCET (2021)
Risk of Arterial Ischemic Events After Intracerebral Hemorrhage
Santosh B. Murthy et al.
STROKE (2020)
Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials
Xiaodan Zhang et al.
CARDIOVASCULAR THERAPEUTICS (2020)
Association Between Subsequent Hospitalizations and Recurrent Acute Myocardial Infarction Within 1 Year After Acute Myocardial Infarction
Yun Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature review
Marissa Blieden Betts et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2020)
Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease
Krishna G. Aragam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake
Julian O. Kim et al.
Cancer Prevention Research (2020)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett et al.
CIRCULATION (2019)
Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review
Lik-Hui Lau et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Value of genetic testing in the prevention of coronary heart disease events
Yrjana Hynninen et al.
PLOS ONE (2019)
Adherence to Statin Therapy Among US Adults Between 2007 and 2014
Lisandro D. Colantonio et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study
Sen Li et al.
DIABETES & METABOLISM JOURNAL (2019)
Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Cost-Effectiveness Analysis
Jamie Jarmul et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Economic Costs of Diabetes in the US in 2017
Wenya Yang et al.
DIABETES CARE (2018)
Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Cost-Effectiveness Analysis
Jamie Jarmul et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta-Analysis
Marion Boulanger et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Long-Term Mortality of Older Patients With Acute Myocardial Infarction Treated in US Clinical Practice
Ajar Kochar et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
Amit V. Khera et al.
NATURE GENETICS (2018)
Duration of Heightened Ischemic Stroke Risk After Acute Myocardial Infarction
Alexander E. Merkler et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
A Systematic Review of Genetic Testing and Lifestyle Behaviour Change: Are We Using High-Quality Genetic Interventions and Considering Behaviour Change Theory?
Justine Horne et al.
LIFESTYLE GENOMICS (2018)
Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin
Dominic Mitchell et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Health Spending By State 1991-2014: Measuring Per Capita Spending By Payers And Programs
David Lassman et al.
HEALTH AFFAIRS (2017)
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
Pradeep Natarajan et al.
CIRCULATION (2017)
Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population
David M. Kern et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Patient-level costs of major cardiovascular conditions: a review of the international literature
Gina Nicholson et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2016)
Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures
Xue Song et al.
BMC HEALTH SERVICES RESEARCH (2015)
Association between hemoglobin A1C levels and clinical outcome in ischemic stroke patients with or without diabetes
Chunyan Lei et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Life Expectancy and Years of Potential Life Lost After Acute Myocardial Infarction by Sex and Race A Cohort-Based Study of Medicare Beneficiaries
Emily M. Bucholz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Stroke Incidence and Mortality Trends in US Communities, 1987 to 2011
Silvia Koton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Costs of Hospitalization for Stroke Patients Aged 18-64 Years in the United States
Guijing Wang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
COST OF ILLNESS FOR NEUROMUSCULAR DISEASES IN THE UNITED STATES
Jane Larkindale et al.
MUSCLE & NERVE (2014)
How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
Patricia Maningat et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Quality of life after TIA and stroke Ten-year results of the Oxford Vascular Study
Ramon Luengo-Fernandez et al.
NEUROLOGY (2013)
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
Eleni Linos et al.
ARTHRITIS RESEARCH & THERAPY (2013)
The Disparity in Long-Term Survival after a First Stroke in Patients with and without Diabetes Persists: The Northern Sweden MONICA Study
Marie Eriksson et al.
CEREBROVASCULAR DISEASES (2012)
Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans Results from Translating Research Into Action for Diabetes (TRIAD)
Ping Zhang et al.
DIABETES CARE (2012)
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Uwe Siebert et al.
MEDICAL DECISION MAKING (2012)
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
Andrew H. Briggs et al.
VALUE IN HEALTH (2012)
Statin-induced myopathy: a review and update
Thura T. Abd et al.
EXPERT OPINION ON DRUG SAFETY (2011)
Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
Bruce Ovbiagele et al.
NEUROTHERAPEUTICS (2011)
Cost Estimation of Cardiovascular Disease Events in the US
Amy K. O'Sullivan et al.
PHARMACOECONOMICS (2011)
Cost Associated with Stroke: Outpatient Rehabilitative Services and Medication
Kyler M. Godwin et al.
TOPICS IN STROKE REHABILITATION (2011)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Populating an Economic Model with Health State Utility Values: Moving toward Better Practice
Roberta Ara et al.
VALUE IN HEALTH (2010)
Rates and probabilities in economic modelling - Transformation, translation and appropriate application
Rachael L. Fleurence et al.
PHARMACOECONOMICS (2007)
Preference-based EQ-5D index scores for chronic conditions in the United States
Patrick W. Sullivan et al.
MEDICAL DECISION MAKING (2006)
Recurrent stroke and cardiac risks after first ischemic stroke - The Northern Manhattan Study
MS Dhamoon et al.
NEUROLOGY (2006)
Outcomes in 45 patients with statin-associated myopathy
KE Hansen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Risk for myopathy with statin therapy in high-risk patients
CM Ballantyne et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Handling uncertainty in cost-effectiveness models
AH Briggs
PHARMACOECONOMICS (2000)
分享论文
